早发型与晚发型子痫前期均以高心输出量为特征,但合并胎儿生长受限时心输出量降低:一项前瞻性研究的启示
该前瞻性研究纳入45例病理妊娠(14例单纯子痫前期、16例单纯胎儿生长受限、15例子痫前期合并胎儿生长受限)与107例健康孕妇对照,用惰性气体再呼吸法测心输出量。结果显示子痫前期伴高心输出量,合并胎儿生长受限时心输出量降低,血流动力学特征与发病孕龄无关而与是否合并胎儿生长受限相关。
要点
- 子痫前期心输出量Z评分较健康对照升高(1.87±1.35),外周血管阻力Z评分降低(-0.76±0.89)。
- 子痫前期合并胎儿生长受限者心输出量Z评分降低(-0.80±1.3),外周血管阻力Z评分升高(2.16±1.96)。
- 子痫前期的血流动力学特征与发病孕龄无关,而与是否合并胎儿生长受限密切相关。
核心结论
- 子痫前期与高心输出量相关,但若子痫前期合并胎儿生长受限则表现为低心输出量;两者均以高血压为定义特征。
- 不合并子痫前期的胎儿生长受限与外周血管阻力升高相关。
- 子痫前期的血流动力学特征与发病孕龄无关,而与是否合并胎儿生长受限密切相关;胎儿生长受限在早孕期更常与子痫前期共存,从而解释既往研究结果的矛盾。
- 抗高血压药物通过降低心输出量或外周血管阻力起效,但在子痫前期中使用时未参考心血管功能状态。
- 潜在病理(子痫前期、胎儿生长受限、子痫前期合并胎儿生长受限)决定心血管表型,为以高或低心输出量或外周血管阻力为主要特征时选择治疗提供合理基础。
研究设计与样本
- 前瞻性研究,纳入45例病理妊娠(14例单纯子痫前期、16例单纯胎儿生长受限、15例子痫前期合并胎儿生长受限)与107例健康孕妇观察对照。
- 心输出量采用惰性气体再呼吸法(Innocor)评估,并由此推导外周血管阻力;动脉功能采用基于袖带的示波法设备Vicorder评估。
- 心血管参数以Z评分按孕龄相对于健康妊娠进行标准化,从而可在24-40周孕龄范围内进行比较。
主要发现
- 与健康对照妊娠相比,子痫前期患者心输出量Z评分更高(1.87±1.35;P=0.0001),外周血管阻力Z评分更低(-0.76±0.89;P=0.025)。
- 胎儿生长受限患者外周血管阻力Z评分更高(0.57±1.18;P=0.04)。
- 子痫前期合并胎儿生长受限患者心输出量Z评分更低(-0.80±1.3;P=0.007),外周血管阻力Z评分更高(2.16±1.96;P=0.0001)。
- 上述变化与发病孕龄无关。
- 所有受子痫前期和/或胎儿生长受限影响者均出现异常升高的增强指数和脉搏波传导速度。
临床怎么用
- 作者认为,潜在病理(子痫前期、胎儿生长受限、子痫前期合并胎儿生长受限)决定心血管表型,为以高或低心输出量或外周血管阻力为主要特征时选择治疗提供合理基础。
- 作者指出,抗高血压药物通过降低心输出量或外周血管阻力起效,但在子痫前期中使用时未参考心血管功能状态。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preeclampsia and fetal growth restriction are considered to be placentally mediated disorders. The clinical manifestations are widely held to relate to gestation age at onset with early- and late-onset preeclampsia considered to be phenotypically distinct. Recent studies have reported conflicting findings in relation to cardiovascular function, and in particular cardiac output, in preeclampsia and fetal growth restriction. OBJECTIVE: We conducted this study to examine the possible relation between cardiac output and peripheral vascular resistance in preeclampsia and fetal growth restriction. STUDY DESIGN: We investigated maternal cardiovascular function in relation to clinical subtype in 45 pathological pregnancies (14 preeclampsia only, 16 fetal growth restriction only, 15 preeclampsia and fetal growth restriction) and compared these with 107 healthy person observations. Cardiac output was the primary outcome measure and was assessed using an inert gas-rebreathing method (Innocor), from which peripheral vascular resistance was derived; arterial function was assessed by Vicorder, a cuff-based oscillometric device. Cardiovascular parameters were normalized for gestational age in relation to healthy pregnancies using Z scores, thus allowing for comparison across the gestational range of 24-40 weeks. RESULTS: Compared with healthy control pregnancies, women with preeclampsia had higher cardiac output Z scores (1.87 ± 1.35; P = .0001) and lower peripheral vascular resistance Z scores (-0.76 ± 0.89; P = .025); those with fetal growth restriction had higher peripheral vascular resistance Z scores (0.57 ± 1.18; P = .04) and those with both preeclampsia and fetal growth restriction had lower cardiac output Z scores (-0.80 ± 1.3 P = .007) and higher peripheral vascular resistance Z scores (2.16 ± 1.96; P = .0001). These changes were not related to gestational age of onset. All those affected by preeclampsia and/or fetal growth restriction had abnormally raised augmentation index and pulse wave velocity. Furthermore, in preeclampsia, low cardiac output was associated with low birthweight and high cardiac output with high birthweight (r = 0.42, P = .03). CONCLUSION: Preeclampsia is associated with high cardiac output, but if preeclampsia presents with fetal growth restriction, the opposite is true; both conditions are nevertheless defined by hypertension. Fetal growth restriction without preeclampsia is associated with high peripheral vascular resistance. Although early and late gestation preeclampsias are considered to be different diseases, we show that the hemodynamic characteristics of preeclampsia were unrelated to gestational age at onset but were strongly associated with the presence or absence of fetal growth restriction. Fetal growth restriction more commonly coexists with preeclampsia at early gestation, thus explaining the conflicting results of previous studies. Furthermore, antihypertensive agents act by reducing cardiac output or peripheral vascular resistance and are administered without reference to cardiovascular function in preeclampsia. The underlying pathology (preeclampsia, fetal growth restriction, preeclampsia and fetal growth restriction) defines cardiovascular phenotype, providing a rational basis for choice of therapy in which high or low cardiac output or peripheral vascular resistance is the predominant feature.
引用
- Tay J, Foo L, Masini G, et al. Early and late preeclampsia are characterized by high cardiac output, but in the presence of fetal growth restriction, cardiac output is low: insights from a prospective study. Am J Obstet Gynecol. 2018. PMID: 29474844. doi:10.1016/j.ajog.2018.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。